Omeros reported $-50766000 in Operating Profit for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Profit Change
Acelrx Pharmaceuticals ACRX:US USD -6632000 6.94M
Adma Biologics ADMA:US USD 22.12M 31.29M
Alnylam Pharmaceuticals ALNY:US USD -334626000 142.94M
Biomarin Pharmaceutical BMRN:US USD -2417000 41.57M
Cytokinetics CYTK:US USD -130687000 119.81M
Dynavax Technologies DVAX:US USD 61.4M 66.83M
Gilead Sciences GILD:US USD 2.84B 808M
Heron Therapeutics HRTX:US USD -41882000 7.62M
Insmed INSM:US USD -127697000 39.38M
Intercept Pharmaceuticals ICPT:US USD -101903000 88.54M
Knight Therapeutics Inc GUD:CN CAD -11333000 14.22M
Macrogenics MGNX:US USD -24955000 16.85M
Mirati Therapeutics MRTX:US USD -186443000 9.24M
Omeros OMER:US USD -50766000 13.33M
Pacira Pharmaceuticals PCRX:US USD 21.29M 9.95M
Pfizer PFE:US USD 9.41B 2.69B
Regulus Therapeutics RGLS:US USD -7563000 388K
Rockwell Medical RMTI:US USD -3708000 774K
Sangamo Biosciences SGMO:US USD -54894000 9.16M
Sarepta Therapeutics SRPT:US USD -256796000 45.66M
United Therapeutics UTHR:US USD 314.3M 112.5M
Vertex Pharmaceuticals VRTX:US USD 1.13B 20.4M
Vital Therapies VTL:US USD -20116000 494K
Xoma XOMA:US USD -4372000 395K